SPCE vs. CLOV, RKLB, ASC, SB, CLCO, BLDE, ESEA, PANL, PAMT, and GASS
Should you be buying Virgin Galactic stock or one of its competitors? The main competitors of Virgin Galactic include Clover Health Investments (CLOV), Rocket Lab (RKLB), Ardmore Shipping (ASC), Safe Bulkers (SB), Cool (CLCO), Blade Air Mobility (BLDE), Euroseas (ESEA), Pangaea Logistics Solutions (PANL), PAMT (PAMT), and StealthGas (GASS).
Virgin Galactic vs. Its Competitors
Clover Health Investments (NASDAQ:CLOV) and Virgin Galactic (NYSE:SPCE) are related small-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.
Clover Health Investments has higher revenue and earnings than Virgin Galactic. Clover Health Investments is trading at a lower price-to-earnings ratio than Virgin Galactic, indicating that it is currently the more affordable of the two stocks.
Clover Health Investments currently has a consensus target price of $4.83, suggesting a potential upside of 67.24%. Virgin Galactic has a consensus target price of $4.81, suggesting a potential upside of 73.74%. Given Virgin Galactic's higher possible upside, analysts clearly believe Virgin Galactic is more favorable than Clover Health Investments.
Clover Health Investments has a net margin of -1.69% compared to Virgin Galactic's net margin of -5,972.70%. Clover Health Investments' return on equity of -7.42% beat Virgin Galactic's return on equity.
19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 46.6% of Virgin Galactic shares are held by institutional investors. 24.1% of Clover Health Investments shares are held by company insiders. Comparatively, 0.4% of Virgin Galactic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Clover Health Investments has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500. Comparatively, Virgin Galactic has a beta of 2.09, indicating that its stock price is 109% more volatile than the S&P 500.
In the previous week, Clover Health Investments had 5 more articles in the media than Virgin Galactic. MarketBeat recorded 8 mentions for Clover Health Investments and 3 mentions for Virgin Galactic. Clover Health Investments' average media sentiment score of 0.61 beat Virgin Galactic's score of 0.32 indicating that Clover Health Investments is being referred to more favorably in the media.
Summary
Clover Health Investments beats Virgin Galactic on 11 of the 16 factors compared between the two stocks.
Get Virgin Galactic News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPCE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SPCE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Virgin Galactic Competitors List
Related Companies and Tools
This page (NYSE:SPCE) was last updated on 7/7/2025 by MarketBeat.com Staff
Free SPCE Stock Alerts